Veterinary Ortho-Prosthetics Market Intelligence: Size, Share and Growth Outlook Through 2035

Market Overview

Size, mix, and clinical demand

• Brevintel analysis values the veterinary ortho-prosthetics market at USD 61.3 million in 2025, expanding from USD 66.2 million in 2026 ($66.2M) to USD 145 million by 2035 ($145M).
• Headline cards list $66.2M, $145M, and 10.2% CAGR, while the narrative 2026-2035 path uses a 9.1% global CAGR.
• OrthoPets led with over 15% share in 2025; OrthoPets, Animal Ortho Care, Walkin' Pets, My Pet's Brace, and K 9 Orthotics & Prosthetics collectively held 55%.
• U.S. pet industry expenditure reached USD 158B (USD 158 billion) in 2025, including USD 41B for veterinary care and product sales.
• North America accounted for 47% of global revenue, or approximately USD 28.8M (USD 28.8 million), in 2025, while Europe represented USD 15.3M (USD 15.3 million).
• Asia Pacific is forecast to grow at a 10.2% CAGR through 2035, above the 9.1% global rate.
• 95 million U.S. households owned pets in 2025, while Europe had 139 million (139M) pet-owning households across 41 countries.
• The category covers custom orthotic braces and prosthetic limbs for trauma, amputation, congenital malformation, degenerative joint disease, and post-surgical limits.

Device design and conversion to fitted care

• Device design must account for species-specific anatomy, gait, loading, skin tolerance, and owner compliance rather than scaled-down human orthotics.
• Non-invasive exoprostheses remain the principal prosthetic format because fitting can be adjusted without surgery, with published canine work showing functional gains alongside skin-monitoring needs.
• Demand is concentrated in companion animals, particularly dogs requiring stifle, carpal, tarsal, or limb-replacement devices.
• Brevintel analysis indicates the rise from USD 61.3 million in 2025 to USD 145 million in 2035 depends less on generalized pet spending than on converting orthopedic diagnoses into fitted-device plans.
• The 9.1% CAGR is supported by that addressable companion-animal base: 95 million U.S. pet-owning households and 139 million European households in 41 countries.
• A custom device creates value only when assessment, scanning or casting, fitting, owner training, and follow-up are coordinated.
• Suppliers that standardize this pathway with hospitals and rehabilitation providers can use additive manufacturing's lower iteration cost without treating printing as a substitute for clinical oversight.
• Referral practices, not headline pet retail spend, determine whether 2026-2035 volume materializes in fitted devices.

Market Dynamics

Growth drivers

• APPA recorded dog ownership in 71 million U.S. households in 2025, and FEDIAF reported approximately 299M pets across 41 European countries.
• China's dog and cat population reached 124.1 million in 2024, including 52.6 million dogs and 71.5 million cats, enlarging the pool exposed to injury, degeneration, and rehabilitation.
• Research on veterinary orthotics and prosthetics has shown that 3D printing can shorten the path from anatomical data to a physical device, including 3D-printed PLA exoprostheses in canine use.
• Scanning, computer-aided design, adjustable range-of-motion systems, and vision-based gait analysis improve reproducibility across referral networks.
• North American pet insurance written premium totaled USD 5.2B in 2024, while U.S. insurance penetration reached 4.3% overall, including 6.0% among dogs, in 2025.
• Bionic Pets lists partial-limb prosthetics at USD 1,345 and custom canine stifle braces at USD 895, illustrating the out-of-pocket threshold insurance can reduce.
• The Association for Pet Obesity Prevention reported that 59% of dogs and 61% of cats evaluated by U.S. veterinary professionals in 2022 were overweight or obese.
• A large U.S. primary-care study found overweight or obesity prevalence of 44.5% in adult dogs, 50.1% in mature dogs, and 47.2% in adult cats; more than 90% of cats older than 12 years show degenerative joint disease.
• The AVMA recognizes 22 veterinary specialty organizations across 46 disciplines; ACVS certification requires an internship, a three-year residency, research publication, and a specialty examination.

Restraints and access gaps

• Custom devices require referral, examination, measurement or casting, fabrication, fitting, and iterative adjustment, capabilities still concentrated in major metropolitan centers in many emerging markets.
• China's 124.1 million dog-and-cat population shows addressable scale, but specialist access and custom-device delivery remain uneven outside leading cities.
• Imported devices can increase cost and turnaround time when fitting changes are required, making local clinical relationships and feedback loops operational necessities.
• In lower-penetration markets, delayed veterinary presentation narrows the window for early bracing, rehabilitation, and conservative mobility intervention.
• The absence of broad insurance coverage leaves owners responsible for specialist consultation, imaging, fabrication, and fitting costs at the point of care.
• Brevintel analysis frames the main restraint as a two-sided infrastructure problem: owner awareness rises when clinicians demonstrate devices, while clinicians need predictable demand to build fitting capability.
• That gap helps explain why Asia Pacific can sustain a 10.2% forecast CAGR while still facing substantial near-term access constraints.
• Practical entry is likely concentrated in urban specialty hospitals, teaching institutions, and rehabilitation providers that can generate evidence and referral habits.

Segmentation Analysis

Product and application

• Prosthetics accounted for 60.8% of market revenue in 2025 and are projected to grow at a 9.5% CAGR through 2035, compared with 8.4% for orthotics.
• The prosthetics category includes exoprostheses, endoprostheses, and osseointegrated solutions, reflecting high-value limb-loss cases from trauma, neoplasia, and severe congenital malformation.
• A systematic review of canine exoprosthesis studies found mobility and quality-of-life improvement, while suspension problems and skin lesions remain persistent design challenges.
• Orthotics address cranial cruciate ligament injury, carpal and tarsal hyperextension, osteoarthritis, and post-operative stabilization, with stifle braces important in both conservative and rehabilitation use.
• Trauma and injury applications are projected to reach USD 54.7 million by 2035.
• A prospective canine evaluation found that 11 of 12 dogs achieved quadrupedal gait after prosthesis fitting, with objective assessment confirming functional weight distribution.
• In UK primary-care dogs, appendicular osteoarthritis had a documented annual period prevalence of 2.5%, with underlying prevalence estimated at approximately 20%.
• Other research identified radiographic osteoarthritis in at least one joint in 39.8% of clinically screened dogs, supporting recurring degenerative-device demand.

Material, technique, animal type, and end use

• Plastic and polymers are forecast to record a 9.2% CAGR through 2035, with PLA, thermoplastic polyurethane, polypropylene, and high-density polyethylene supporting thermoforming and additive workflows.
• Metals and implant-oriented materials serve endoprosthetic and osseointegrated cases; ceramics and composites, including carbon-fiber, remain specialized high-load options.
• The 3D printing segment generated USD 42.2 million in 2025, representing approximately 69% of the USD 61.3 million market, confirming additive manufacturing as the dominant technique.
• Molding retains relevance for soft orthoses, padded supports, and anatomically difficult regions where manual shaping and flexible materials remain advantageous.
• Companion animals are projected to generate USD 50.2 million by 2035, with dogs dominating volume through cruciate injury, trauma, dysplasia, and limb loss.
• Cats are a growing support-device opportunity in older degenerative populations; horses are a smaller high-value niche, and livestock applications remain limited by production economics.
• Veterinary hospitals accounted for 43.7% of revenue in 2025, reflecting access to imaging, surgical teams, anesthesia, rehabilitation, and referral caseloads.
• Orthopedic clinics handle complex cases, while rehabilitation centers expand post-operative and chronic mobility management, often overlapping with hospital identification of candidates.

Regional Outlook

North America and Europe

• North America generated approximately USD 28.8 million in 2025, equivalent to 47% of global market revenue.
• The U.S. market expanded from USD 20.8 million in 2022 to USD 22.4 million in 2023, USD 24.2 million in 2024, and USD 26.2 million in 2025.
• U.S. dog ownership reached 53% of households in 2025, while North American insurance activity reached USD 5.2B in written premium in 2024.
• Custom fitting still depends on specialist assessment and trained delivery capacity, so referral relationships and clinical training remain growth constraints.
• Canada contributes through specialist providers such as K-9 Orthotics & Prosthetics, which maintains research relationships with veterinary teaching colleges across North America.
• Europe represented USD 15.3 million in 2025 and benefits from 139M pet-owning households and approximately 299M pets across 41 European countries.
• The UK, Germany, France, Italy, Spain, the Netherlands, and Nordic countries provide the principal demand base, though reimbursement and device access differ by country.
• Insurance penetration is a meaningful advantage in the UK and Nordic markets, with comparatively stronger use in the UK and Germany than in most other European markets.

Asia Pacific, Latin America, and Middle East & Africa

• Asia Pacific is projected to grow at a 10.2% CAGR through 2035, exceeding the global 9.1% rate.
• China recorded 124.1 million dogs and cats in 2024; Japan and Australia have more developed referral and insurance structures, while South Korea, India, and Southeast Asia offer longer-term potential.
• Regional growth is constrained by uneven specialist distribution and concentration of advanced fabrication in large urban centers.
• Latin America remains early-stage, with Brazil and Mexico accounting for a substantial share of regional potential, including a Brazilian case of a custom 3D prosthesis after hind-limb amputation.
• Broad commercialization there remains limited by uneven specialty infrastructure and the absence of pet insurance at scale.
• Middle East & Africa remain nascent, with demand concentrated in premium centers, particularly in the UAE and South Africa.
• Brevintel analysis expects North America to keep the strongest current revenue base, while Asia Pacific's 10.2% forecast converts only where metropolitan referral and fabrication become accessible.
• Europe is the most immediate expansion setting outside North America; Latin America and Middle East & Africa remain longer-dated opportunities.

Competitive Landscape

Structure and recent company events

• The market is moderately concentrated, with the five largest companies accounting for approximately 55% of global revenue in 2025.
• Competition splits between dedicated custom-device specialists and diversified veterinary orthopedic suppliers with hospital implant portfolios.
• OrthoPets was founded in 2003 in Westminster, Colorado, by Martin Kaufmann and reported serving more than 30,000 patients across 35 countries.
• Its November 2025 Chapter 7 filing listed assets of USD 326,057 against liabilities of USD 657,216, with revenue of USD 1.6 million in 2024.
• Animal Ortho Care lists a custom knee brace at USD 895 and bilateral devices at USD 1,690.
• Walkin' Pets, founded in 2001 in Amherst, New Hampshire, has served more than 1.8 million pets and in January 2024 introduced a veterinary-exclusive line and a K9 Orthotics & Prosthetics Division.
• My Pet's Brace, founded in 2010, stated it had fabricated 22,948 braces by January 2026, worked with 5,535 veterinarians and rehabilitation professionals, and served all 50 U.S. states and 32 countries.
• K-9 Orthotics & Prosthetics, based in Beaver Bank, Nova Scotia, was founded by certified orthotist and prosthetist Jeff Collins.
• Bionic Pets, headquartered in Purcellville, Virginia, and founded by Derrick Campana, states that it has served more than 35,000 animals globally.
• Thera-Paw, founded in 2001 by Ilaria Borghese and based in Lebanon, New Jersey, reports more than 25,000 unique custom devices fabricated.
• DePuy Synthes, a Johnson & Johnson company, supplies locking compression plates, pelvic osteotomy systems, and fracture-repair implants for small and large animals.
• Veterinary Orthopaedic Implants (VOI), part of the Movora family of brands and founded in 1992, supplies TPLO, CBLO, TTA, arthrodesis, and limb-salvage implants.

Custom-device specialists

• OrthoPets
• Animal Ortho Care
• Walkin' Pets
• My Pet's Brace
• K 9 Orthotics & Prosthetics
• Petsthetics
• Specialized Pet Solutions
• Bionic Pets
• Anchor Orthotics & Prosthetics
• OrthoPaws
• Animal Prosthetics
• Thera-Paw

Diversified orthopedic suppliers

• DePuy Synthes
• Veterinary Orthopaedic Implants (VOI)